# Atea Pharmaceuticals, Inc.: Form SCHEDULE 13D/A, filed Mar 21, 2025

- Company: [Atea Pharmaceuticals, Inc.](/companies/avir.md) (CIK 1593899)
- Form: SCHEDULE 13D/A
- Filed: 2025-03-21
- Accepted by EDGAR: Mar 21, 2025, 15:58 ET
- Period: not reported
- Accession: 0000921895-25-000843
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1593899/000092189525000843/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1593899/000092189525000843/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1593899/000092189525000843/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 21, 2025.
Source: SEC EDGAR, the filing index for accession 0000921895-25-000843. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.